85 related articles for article (PubMed ID: 2561059)
1. X-linked lymphoproliferative syndrome.
Sullivan JL; Woda BA
Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
[TBL] [Abstract][Full Text] [Related]
2. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.
Kanegane H; Ito Y; Ohshima K; Shichijo T; Tomimasu K; Nomura K; Futatani T; Sumazaki R; Miyawaki T
Am J Hematol; 2005 Feb; 78(2):130-3. PubMed ID: 15682426
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
4. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
Cohen JI
Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
[TBL] [Abstract][Full Text] [Related]
5. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.
Rigaud S; Fondanèche MC; Lambert N; Pasquier B; Mateo V; Soulas P; Galicier L; Le Deist F; Rieux-Laucat F; Revy P; Fischer A; de Saint Basile G; Latour S
Nature; 2006 Nov; 444(7115):110-4. PubMed ID: 17080092
[TBL] [Abstract][Full Text] [Related]
6. The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome.
Plunkett FJ; Franzese O; Belaramani LL; Fletcher JM; Gilmour KC; Sharifi R; Khan N; Hislop AD; Cara A; Salmon M; Gaspar HB; Rustin MH; Webster D; Akbar AN
Mech Ageing Dev; 2005 Aug; 126(8):855-65. PubMed ID: 15992610
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
Yachie A; Kanegane H; Kasahara Y
Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
[TBL] [Abstract][Full Text] [Related]
8. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
Schuster V; Kreth HW
Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
[TBL] [Abstract][Full Text] [Related]
9. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated lymphoproliferative disorders.
Rezk SA; Weiss LM
Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
[TBL] [Abstract][Full Text] [Related]
11. CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission.
Marshall NA; Culligan DJ; Johnston PW; Millar C; Barker RN; Vickers MA
Br J Haematol; 2007 Oct; 139(1):81-9. PubMed ID: 17854310
[TBL] [Abstract][Full Text] [Related]
12. Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses.
Miyawaki T
Iran J Allergy Asthma Immunol; 2004 Jun; 3(2):51-7. PubMed ID: 17301392
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development.
Nagy N; Klein E
Immunol Lett; 2010 May; 130(1-2):13-8. PubMed ID: 20080127
[TBL] [Abstract][Full Text] [Related]
14. Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female.
Woon ST; Ameratunga R; Croxson M; Taylor G; Neas K; Edkins E; Browett P; Gane E; Munn S
Scand J Immunol; 2008 Aug; 68(2):153-8. PubMed ID: 18702745
[TBL] [Abstract][Full Text] [Related]
15. X-linked lymphoproliferative syndromes and related autosomal recessive disorders.
Veillette A; Pérez-Quintero LA; Latour S
Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):614-22. PubMed ID: 24113228
[TBL] [Abstract][Full Text] [Related]
16. Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection.
Malbran A; Belmonte L; Ruibal-Ares B; Baré P; Massud I; Parodi C; Felippo M; Hodinka R; Haines K; Nichols KE; de Bracco MM
Blood; 2004 Mar; 103(5):1625-31. PubMed ID: 14604960
[TBL] [Abstract][Full Text] [Related]
17. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.
Sumazaki R; Kanegane H; Osaki M; Fukushima T; Tsuchida M; Matsukura H; Shinozaki K; Kimura H; Matsui A; Miyawaki T
Blood; 2001 Aug; 98(4):1268-70. PubMed ID: 11493483
[TBL] [Abstract][Full Text] [Related]
18. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy.
Milone MC; Tsai DE; Hodinka RL; Silverman LB; Malbran A; Wasik MA; Nichols KE
Blood; 2005 Feb; 105(3):994-6. PubMed ID: 15494422
[TBL] [Abstract][Full Text] [Related]
19. Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease--report of three cases.
Hügle B; Suchowerskyj P; Hellebrand H; Adler B; Borte M; Sack U; Overberg-Schmidt US; Strnad N; Otto J; Meindl A; Schuster V
J Clin Immunol; 2004 Sep; 24(5):515-22. PubMed ID: 15359110
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic defect in B-lymphoblastoid cell lines from patients with X-linked lymphoproliferative disease type 1. I. Cell surface phenotype and functional studies.
Shlapatska LM; Kovalevska LM; Gordiienko IM; Sidorenko SP
Exp Oncol; 2014 Mar; 36(1):2-8. PubMed ID: 24691277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
